21 results on '"Vermij, Lisa"'
Search Results
2. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
3. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
4. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
5. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
6. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
7. EP116/#725 Low-grade p53abn endometrial carcinomas exist and are associated with a high risk of recurrence, even in low-stage disease
8. 2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study
9. 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers
10. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients - a TransPORTEC study
11. Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer
12. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
13. HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
14. Incorporation of molecular characteristics into endometrial cancer management
15. Incorporation of molecular characteristics into endometrial cancer management.
16. ABO incompatibility and RhIG immunoprophylaxis protect against non‐D alloimmunization by pregnancy
17. HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes.
18. Performance of p53 Immunohistochemistry as a Surrogate Marker for TP53 Mutations in the PORTEC-3 Endometrial Carcinoma Cohort
19. Unmethylated Mismatch Repair Deficiency in the Combined PORTEC-1,-2 and-3 Endometrial Cancer Trials: Underlying Causes and Survival Analysis
20. Prognostic Relevance of FIGO Grading is Limited to NSMP Endometrial Carcinomas
21. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.